TABLE 1.
Variable | Treatment group | Control group |
---|---|---|
n | 12 | 9 |
Age, y | 51.6 ± 10.0 | 52.8 ± 8.1 |
Sex, n female, n male | 10, 2 | 9, 0 |
Race/ethnicity, % | ||
Caucasian | 100 | 77.8 |
African American | 0 | 11.1 |
Latino/a | 0 | 11.1 |
Highest level of education, % | ||
High school | 8.3 | 0 |
Some college | 50 | 11.1 |
College graduate | 33.3 | 44.4 |
After college | 8.3 | 44.4 |
Years with diagnosed MS | 10.3 ± 6.2 | 14 ± 9.04 |
BMI, kg/m2 | 29.9 ± 7.1 | 32.30 ± 9.00 |
Expanded Disabilities Scale | 3.5 ± 2.4 | 2.78 ± 2.44 |
Dietary L + Z intake, mg3 | 2.47 ± 2.22 | 2.46 ± 2.11 |
Macular pigment optical density | 0.32 ± 0.26 | 0.46 ± 0.27 |
Skin carotenoids, VM units | 240 ± 57 | 292 ± 84 |
Serum lutein, μmol/L4 | 0.13 ± 0.06 | 0.19 ± 0.11 |
L + Z, lutein and zeaxanthin; MS, multiple sclerosis; VM, Veggie Meter.
Continuous data expressed as mean ± SD.
Baseline group equivalence was assessed at baseline using independent t tests. No significant differences were observed between the 2 groups at baseline.
Treatment group n = 5, control group n = 7.
Control group n = 8.